BioLargo, Inc. BLGO
$0.09
$0.00-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 11.93% | 80.71% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.93% | 80.71% | |||
| Cost of Revenue | -12.79% | 34.36% | |||
| Gross Profit | 47.38% | 257.81% | |||
| SG&A Expenses | 20.33% | -20.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.21% | -6.39% | |||
| Operating Income | -16.35% | 19.84% | |||
| Income Before Tax | -17.47% | 17.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -17.47% | 17.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 10.19% | -5.89% | |||
| Net Income | -21.04% | 22.59% | |||
| EBIT | -16.35% | 19.84% | |||
| EBITDA | -16.71% | 20.67% | |||
| EPS Basic | -19.44% | 23.40% | |||
| Normalized Basic EPS | -21.88% | 27.27% | |||
| EPS Diluted | -19.44% | 23.40% | |||
| Normalized Diluted EPS | -21.88% | 27.27% | |||
| Average Basic Shares Outstanding | 0.72% | 1.40% | |||
| Average Diluted Shares Outstanding | 0.72% | 1.40% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||